Intra-articular Hyaluronan Substitution in Arthroscopy of the Wrist

See also
Status	Clinical Trial	Phase
Completed	`NCT00739947` - Arthroscopic Surgical Outcome Study In Subjects With Rotator Cuff Tears
Not yet recruiting	`NCT06086223` - Functional Outcomes Following Ankle Fracture Fixation With or Without Ankle Arthroscopy	N/A
Completed	`NCT05721547` - Alterations in Spinal Alignment and Mobility in Individuals With Arthroscopic Rotator Cuff Repair
Terminated	`NCT03805698` - Use of Platelet Rich Plasma After Arthroscopic Debridement for Triangular Fibrocartilage Complex Tears	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT00739947 - Arthroscopic Surgical Outcome Study In Subjects With Rotator Cuff Tears

Not yet recruiting

NCT06086223 - Functional Outcomes Following Ankle Fracture Fixation With or Without Ankle Arthroscopy

N/A

Completed

NCT05721547 - Alterations in Spinal Alignment and Mobility in Individuals With Arthroscopic Rotator Cuff Repair

Terminated

NCT03805698 - Use of Platelet Rich Plasma After Arthroscopic Debridement for Triangular Fibrocartilage Complex Tears

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01254682
Study type	Interventional
Source	TRB Chemedica AG
Contact
Status	Completed
Phase	N/A
Start date	January 2007
Completion date	August 2009

Intra-articular Hyaluronan Substitution in Arthroscopy of the Wrist

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms